Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schlesinger

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|January 3, 2022
Editorial: The Role of Platelets in Cancer Progression and MalignancyMartin Schlesinger, Martina Gobec, Alexander T Bauer
International Journal of Molecular Sciences|April 3, 2021
A Combined Activity of Thrombin and P-Selectin Is Essential for Platelet Activation by Pancreatic Cancer CellsReza Haschemi, Lukas Maria Gockel, Gerd Bendas, et al.
Molecules (Basel, Switzerland)|October 24, 2018
Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer CellsJan Moritz Ponert, Lukas Maria Gockel, Svenja Henze, et al.
Biophysical Chemistry|February 19, 2010
Analysis of SM4 sulfatide as a P-selectin ligand using model membranesDirk Simonis, Martin Schlesinger, Christian Seelandt, et al.
Thrombosis and Haemostasis|November 6, 2009
Binding between heparin and the integrin VLA-4Martin Schlesinger, Dirk Simonis, Patrick Schmitz, et al.
Cancers|December 20, 2018
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells-Deciphering Novel Potential Targets for a Cell SensitizationBastian Jakubzig, Fabian Baltes, Svenja Henze, et al.
International Journal of Molecular Sciences|July 17, 2020
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β<sub>1</sub>-integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 BindingFabian Baltes, Julia Caspers, Svenja Henze, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2022
Tumour cell-activated platelets modulate the immunological activity of CD4<sup>+</sup>, CD8<sup>+</sup>, and NK cells, which is efficiently antagonized by heparinLukas M Gockel, Katrin Nekipelov, Vito Ferro, et al.
Molecules (Basel, Switzerland)|October 26, 2018
The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent PathwaysLukas Maria Gockel, Jan Moritz Ponert, Svenja Schwarz, et al.
International Journal of Molecular Sciences|November 27, 2021
Insulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer CellsReza Haschemi, Dennis Kobelt, Elisabeth Steinwarz, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|January 3, 2022
Editorial: The Role of Platelets in Cancer Progression and MalignancyMartin Schlesinger, Martina Gobec, Alexander T Bauer
International Journal of Molecular Sciences|April 3, 2021
A Combined Activity of Thrombin and P-Selectin Is Essential for Platelet Activation by Pancreatic Cancer CellsReza Haschemi, Lukas Maria Gockel, Gerd Bendas, et al.
Molecules (Basel, Switzerland)|October 24, 2018
Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer CellsJan Moritz Ponert, Lukas Maria Gockel, Svenja Henze, et al.
Biophysical Chemistry|February 19, 2010
Analysis of SM4 sulfatide as a P-selectin ligand using model membranesDirk Simonis, Martin Schlesinger, Christian Seelandt, et al.
Thrombosis and Haemostasis|November 6, 2009
Binding between heparin and the integrin VLA-4Martin Schlesinger, Dirk Simonis, Patrick Schmitz, et al.
Cancers|December 20, 2018
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells-Deciphering Novel Potential Targets for a Cell SensitizationBastian Jakubzig, Fabian Baltes, Svenja Henze, et al.
International Journal of Molecular Sciences|July 17, 2020
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β<sub>1</sub>-integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 BindingFabian Baltes, Julia Caspers, Svenja Henze, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2022
Tumour cell-activated platelets modulate the immunological activity of CD4<sup>+</sup>, CD8<sup>+</sup>, and NK cells, which is efficiently antagonized by heparinLukas M Gockel, Katrin Nekipelov, Vito Ferro, et al.
Molecules (Basel, Switzerland)|October 26, 2018
The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent PathwaysLukas Maria Gockel, Jan Moritz Ponert, Svenja Schwarz, et al.
International Journal of Molecular Sciences|November 27, 2021
Insulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer CellsReza Haschemi, Dennis Kobelt, Elisabeth Steinwarz, et al.
Pageof 5